Sulfadimethoxine (SDM) is a long-acting sulfonamide antimicrobial that occupies a specialized position in veterinary medicine. Unlike short-acting sulfonamides such as Sulfamethoxazole, SDM is characterized by its extended plasma half-life, which allows for once-daily or alternate-day dosing—a significant advantage in livestock and poultry operations where labor costs and handling stress are concerns .
Structurally, it is a di-methoxy substituted sulfonamide derivative, sharing the same core mechanism as other sulfa drugs: competitive antagonism of para-aminobenzoic acid (PABA) in the bacterial folate biosynthesis pathway. Its distinguishing feature is its favorable pharmacokinetic profile—high bioavailability, extensive tissue distribution, and slow renal elimination—making it particularly valuable in food-producing animals where it remains one of the few sulfonamides with approved veterinary indications in many markets .
Mechanism of Action:Sulfadimethoxine exerts its antimicrobial effect through the same fundamental mechanism as all sulfonamides: competitive antagonism of PABA in the bacterial folate biosynthesis pathway .
